Rail Vikas Nigam has secured significant infrastructure contracts, receiving a Letter of Acceptance (LoA) from East Coast Railway for bridge construction on EPC mode for the 3rd and 4th railway lines between Nergundi–Barang and Khurda Road–Vizianagaram on the Bhadrak–Vizianagaram section. According to reports, the order is valued at ₹967.92 crore. Additionally, the company has received a contract worth ₹2,666.09 crore from Rail Vikas Nigam for the BharatNet Phase-III project in Uttar Pradesh, covering supply of telecom equipment, optical fiber cable network creation, and 10-year maintenance services.
NHPC Limited has signed a Memorandum of Agreement (MoA) with Government of Arunachal Pradesh on June 16, 2026, for the implementation of Etalin HEP (3097 MW). The project will be developed on Build, Own, Operate and Transfer (BOOT) basis for a lease period of 40 years from Commercial Operating Date (COD). As per the MoA, NHPC will undertake preliminary investigation for Pre-feasibility Report, detailed investigation for DPR preparation, financing and subsequent development, commissioning, implementation, operation and maintenance of the hydroelectric project on Dri & Tangon rivers in Dibang Basin. The project will be developed as a run-of-the-river scheme in accordance with the State of Arunachal Pradesh Hydro Power Policy, 2008.
Bosch Global Software Technologies will sell up to a 7.97 percent stake (21.7 lakh shares) in Bosch Home Comfort through an offer-for-sale on June 18-19, with a floor price fixed at ₹1,150 per share. As reported, the hospitality company Lemon Tree Hotels announced the opening of a new Lemon Tree Hotel in Sri Ganganagar, Rajasthan, expanding its network to 23 hotels across the state. The company has also appointed Saroj Kumar Khuntia as Chief Financial Officer effective June 18, with Madhusudan Bajaj ceasing to be CFO upon reaching superannuation age.
Lupin announced the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States following US FDA approval for its Abbreviated New Drug Application. According to reports, the product is bioequivalent to Edarbi of Azurity Pharmaceuticals, Inc. and indicated for hypertension treatment in adults. Lupin is the exclusive first-to-file for this product and eligible for 180-day generic drug exclusivity. Additionally, Corona Remedies saw significant institutional activity with Sepia Investments selling 43.28 lakh shares (7.07 percent stake) for ₹748.9 crore at ₹1,730 per share. Glenmark Pharmaceuticals Inc., USA has launched Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial, which is bioequivalent to the reference listed drug ProvayBlue® Injection with annual market sales of approximately $19.0 million according to IQVIA® data.
NHPC Limited shares were trading at ₹74.78 on BSE compared to the previous close of ₹74.61, with a total of 294,523 shares traded across 1,971 trades. The stock hit an intraday high of ₹74.92 and intraday low of ₹74.42, with net turnover of ₹219.96 crore. Glenmark Pharmaceuticals Limited shares were last trading at ₹2156.80 on BSE compared to the previous close of ₹2155.60, with total shares traded of 16,226 across 944 trades. The stock hit an intraday high of ₹2171.55 and intraday low of ₹2133.50, with net turnover of ₹349.06 crore.
